Our Research

Discover our recent findings, catch up with news, and review in-depth resources.

Solving Carboplatin: A Novel LC-MS/MS Assay for Intact Drug Quantitation in Human Plasma

Case Studies

Solving Carboplatin: A Novel LC-MS/MS Assay for Intact Drug Quantitation in Human Plasma

Resolian developed and validated (following ICH-M10) a high-throughput and robust LC MS/MS method for quantifying intact carboplatin in human plasma, overcoming long-standing challenges around isotopic interference, protein binding, and chromatographic retention.
Read more
Effect of Particle Size Reduction on the Surface Energy of Sucrose | Resolian

Case Studies

Surface Energy and Sucrose: Why Milling Method Matters More Than Particle Size

How does milling method affect pharmaceutical powder surfaces? Resolian’s iGC-SEA analysis of sucrose reveals that processing route influences surface energy more significantly than particle size alone.
Read more
Characterising Polymer Nanoparticle Surface Energy for Nanomedicine Research

Case Studies

Understanding Nanoparticle Surfaces: A New Analytical Approach for Nanomedicine Research

Discover how Resolian used iGC-SEA to characterise polymer nanoparticle surface energy for Loughborough University, generating new insights into protein corona formation and nanomedicine development.
Read more
Resolian - USP and USP : What Pharma Manufacturers Need to Know

Blog

USP 665 and USP 1665: What Pharma Manufacturers Need to Know

USP and USP are now mandatory for pharma and biopharma manufacturers using plastic components. Learn what compliance requires and how Resolian’s E&L experts can help.
Read more
Resolian | Making Informed Decisions - A Guide to Selecting the Right Contract Research Organization Partner

Blog

Making Informed Decisions: A Guide to Selecting the Right Contract Research Organization Partner

How do you evaluate a CRO beyond price? This guide covers technical capabilities, quality systems, geographical reach, and partnership factors that matter most.
Read more
Ultra-Low B Cell Detection: Flow Cytometry Method Validation to 10 cells/μL | Resolian Case Study

Case Studies

Ultra-Low B Cell Detection: Flow Cytometry Method Validation to 10 cells/μL

Learn how Resolian developed a validated flow cytometry method achieving B cell detection down to 0.5 cells/μL with 5.27% CV using innovative matrix design.
Read more
Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.